![]() WuXi AppTec WuXi AppTec (无锡药明康德新药开发股份有限公司, formerly known as WuXi PharmaTech) is a company that provides integrated research, development, and manufacturing solutions for drug discovery and production. | ![]() Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. | ![]() AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines. | ![]() Sanofi Sanofi is a healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions. | ||
Founding Date | Founding Date 2000 | Founding Date 1996 | Founding Date 1999 | Founding Date 1896 | Founding Date 1994 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Shanghai, CN HQ Beijing, CN Changzhou, CN Chengdu, CN Nanjing, CN Nantong, CN Shanghai, CN see more | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more | Locations Paris, FR HQ Hydra, DZ Buenos Aires, AR Macquarie Park, AU Melbourne, AU Virginia, AU Wien, AT see more | |
Employees | Employees 39,414 | Employees 75,883 | Employees 94,300 | Employees 103,249 | Employees 82,878 |
Valuation ($) | Valuation ($) 20.7 b | Valuation ($) N/A | Valuation ($) 2.7 b | Valuation ($) N/A | Valuation ($) 141.1 b |
Financial | |||||
Revenue (est.) | Revenue (est.) ¥43.1b (FY, 2025) | Revenue (est.) $56.7b (FY, 2025) | Revenue (est.) $58.7b (FY, 2025) | Revenue (est.) CHF61.5b (FY, 2025) | Revenue (est.) €45.4b (FY, 2025) |
Cost of goods | Cost of goods ¥23.8b (FY, 2025) | Cost of goods $8.4b (FY, 2025) | Cost of goods $4.9b (FY, 2025) | Cost of goods CHF13.1b (FY, 2025) | Cost of goods €11.6b (FY, 2025) |
Gross profit | Gross profit ¥21.3b (FY, 2025) | Gross profit $49.8b (FY, 2025) | Gross profit $54.2b (FY, 2025) | Gross profit CHF50.5b (FY, 2025) | Gross profit €37.6b (FY, 2025) |
Net income | Net income ¥19.3b (FY, 2025) | Net income $14b (FY, 2025) | Net income $10.2b (FY, 2025) | Net income CHF13.8b (FY, 2025) | Net income €8b (FY, 2025) |
Operating ⚠ | |||||
Patients | Patients N/A | Patients 10 m (FY, 2022) | Patients N/A | Patients 22.8 m (FY, 2023) | Patients N/A |
Projects in R&D Pipeline | Projects in R&D Pipeline N/A | Projects in R&D Pipeline N/A | Projects in R&D Pipeline 177 (FY, 2021) | Projects in R&D Pipeline N/A | Projects in R&D Pipeline 91 (FY, 2019) |
Funding | |||||
Total funding raised | Total funding raised $ 902.6m | Total funding raised $ 6.5m | Total funding raised $ 1b | Total funding raised $ 7.8b | Total funding raised $ 310m |

Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View company
AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
View company
Roche Holding is a biotech company that provides in vitro diagnostics and supplies services.
View company
Sanofi is a healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions.
View company